SCHEMBL2200675

SCHEMBL2200675

CCc1cccc(CC)c1Cl

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 4/20 0.55
GABRB2 P47870 4/20 0.55
HTR1A P08908 3/20 0.52
DRD2 P14416 3/20 0.52
DRD4 P21917 3/20 0.52
HTR2A P28223 3/20 0.52
HTR2C P28335 3/20 0.52
DRD3 P35462 3/20 0.52
PNMT P11086 1/20 0.44
CTRC Q99895 1/20 0.39
TAAR1 Q96RJ0 1/20 0.39
IDO1 P14902 2/20 0.38
MGLL Q99685 1/20 0.38
PDK2 Q15119 1/20 0.38
CSNK2A2 P19784 1/20 0.37
CSNK2B P67870 1/20 0.37
CSNK2A1 P68400 1/20 0.37
CSNK2A3 Q8NEV1 1/20 0.37
KCNH2 Q12809 1/20 0.36
SCN5A Q14524 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Nitrogen SCHEMBL10979594 0.95 GABRA1 (0.50) GABRA1GABRB2HTR1ADRD2DRD4
SCHEMBL7788783 0.90 GABRA1 (0.48) GABRA1GABRB2HTR1ADRD2DRD4
SCHEMBL16950743 0.88 GABRA1 (0.50) GABRA1GABRB2HTR1ADRD2DRD4
SCHEMBL17450488 0.88 GABRA1 (0.44) GABRA1GABRB2HTR1ADRD2DRD4
SCHEMBL91279 0.87 PNMT (0.62) GABRA1GABRB2HTR1ADRD2DRD4
SCHEMBL3781759 0.85 GABRA1 (0.46) GABRA1GABRB2HTR1ADRD2DRD4
SCHEMBL6829666 0.85 GABRA1 (0.46) GABRA1GABRB2HTR1ADRD2DRD4
SCHEMBL11637531 0.84 GABRA1 (0.46) GABRA1GABRB2HTR1ADRD2DRD4
SCHEMBL16959855 0.83 GABRA1 (0.45) GABRA1GABRB2HTR1ADRD2DRD4
SCHEMBL573719 0.83 GABRA1 (0.56) GABRA1GABRB2HTR1ADRD2DRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1409699-A Process for preparation of secondary and tertiary amines CELGRO (US) 2003-04-09 CN claimed
EP-1237844-A1 PROCESS FOR THE PREPARATION OF SECONDARY AND TERTIARY AMINES Celgro (US) 2002-09-11 EP claimed
WO-2001044162-A1 PROCESS FOR THE PREPARATION OF SECONDARY AND TERTIARY AMINES CELGRO (US) 2001-06-21 WO claimed
US-6107521-A Process for the preparation of secondary amines CELGRO (US) 2000-08-22 US claimed
CN-110305171-B Preparation and application of mixed nickel (II) complex containing bisoxazoline-derived nitrogen heterocyclic carbene ligand and phosphite ligand 苏州大学 2021-09-28 CN disclosed
CN-110305171-A The preparation and application of mixed matching nickel (II) complex containing nitrogen heterocycle carbine ligand derived from double oxazolines and phosphite ester ligand 苏州大学 2019-10-08 CN disclosed
CN-109422680-A A kind of synthetic method of N- acetylquinoline -2- amide and its derivative 浙江工业大学 2019-03-05 CN disclosed
CN-108299622-A For improving polyurethane(PU)The method of the hydrolytic resistance of matrix system 朗盛德国有限责任公司 2018-07-20 CN disclosed
CN-106146829-B A kind of polymer containing two or more pyrenyl groups and its production and use 烟台大学 2018-01-30 CN disclosed
US-20110230680-A1 LUBRICATING COMPOSITIONS CONTAINING ASHLESS CATALYTIC ANTIOXIDANT ADDITIVES EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2011-09-22 US disclosed
US-7977286-B2 Substituted N,N'-diaryl-m-phenylenediamines impart good levels of oxidation inhibition in lubricants, hydraulic fluids; lubricant is a synthetic oil derived from a Fischer-Tropsch wax via palladium/phosphine complex coupling catalyst; engine, industrial, marine, hydraulic, aviation, driveline oils EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2011-07-12 US disclosed
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-2029706-A2 LUBRICATING COMPOSITIONS CONTAINING ASHLESS CATALYTIC ANTIOXIDANT ADDITIVES ExxonMobil Research and Engineering Company (US) 2009-03-04 EP disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed
WO-2007133462-A2 LUBRICATING COMPOSITIONS CONTAINING ASHLESS CATALYTIC ANTIOXIDANT ADDITIVES EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2007-11-22 WO disclosed
US-20070265178-A1 Lubricating compositions containing ashless catalytic antioxidant additives EXXONMOBIL RESEARCH AND ENGINEERING COMPANY 2007-11-15 US disclosed
CN-1409699-A Process for preparation of secondary and tertiary amines CELGRO (US) 2003-04-09 CN disclosed
US-6107521-A Process for the preparation of secondary amines CELGRO (US) 2000-08-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 GABRA1 991/4885GABRB2 561/4885HTR1A 3657/4885
US-20070265178-A1 Lubricating compositions containing ashless catalytic antioxidant additives GPX4, SOD1, GPX1 GABRA1 4834/4885GABRB2 4822/4885HTR1A 3291/4885
US-20110230680-A1 LUBRICATING COMPOSITIONS CONTAINING ASHLESS CATALYTIC ANTIOXIDANT ADDITIVES GPX4, SOD1, GPX1 GABRA1 4828/4885GABRB2 4817/4885HTR1A 3437/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.